ImmuCell Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| MRK | Merck | Outperform |
2
|
$131.20 | $130.51 | 8.61% | 11 | $321.69B |
| ZTS | Zoetis | Outperform |
18
|
$158.42 | $220.47 | 39.50% | 5 | $66.94B |
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| MRK | Merck | Outperform |
2
|
$131.20 | $130.51 | 8.61% | 11 | $321.69B |
| ZTS | Zoetis | Outperform |
18
|
$158.42 | $220.47 | 39.50% | 5 | $66.94B |